The Fox Chase Chemical Diversity Center, Inc. (FCCDC)

 

The Fox Chase Chemical Diversity Center Announces it Has Been Selected to Participate in the Spring, 2016 I-Corps Program of the National Institutes of Health

 

Doylestown, PA. February 10, 2016- FCCDC is pleased to announce that it has been selected to participate in the spring, 2016 i-Corps program of the National Institutes of Health, in support of an ongoing Phase I SBIR-funded program entitled "Development of Drugs that Target the M2 Proton Channel from Influenza A Virus" (R43 AI104121-01A1).